# PagerDuty, Inc.: financial statements, quarterly

PD · NYSE · CIK 1568100 · [Technology](/sectors/technology.md) · fiscal year ends Jan 31

Pages: [Overview](/companies/pd.md) · [Financials](/companies/pd/financials.md) · [Filings](/companies/pd/filings.md) · [Insiders](/companies/pd/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pd/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [109](/filings/0001568100-24-000139.md) | [111 d](/filings/0001568100-26-000012.md) | [111](/filings/0001568100-25-000051.md) | [116](/filings/0001568100-25-000099.md) | [119](/filings/0001568100-25-000107.md) | [121 d](/filings/0001568100-26-000012.md) | [120](/filings/0001568100-26-000031.md) | [123](/filings/0001568100-26-000045.md) | [125](/filings/0001568100-25-000107.md) | [125 d](/filings/0001568100-26-000012.md) | [121](/filings/0001568100-26-000031.md) | [124](/filings/0001568100-26-000045.md) |
| Cost of revenue | $m | [19.7](/filings/0001568100-24-000139.md) | [20.4 d](/filings/0001568100-26-000012.md) | [19.3](/filings/0001568100-25-000051.md) | [20.1](/filings/0001568100-25-000099.md) | [20.3](/filings/0001568100-25-000107.md) | [20.0 d](/filings/0001568100-26-000012.md) | [19.2](/filings/0001568100-26-000031.md) | [19.0](/filings/0001568100-26-000045.md) | [18.4](/filings/0001568100-25-000107.md) | [17.6 d](/filings/0001568100-26-000012.md) | [19.0](/filings/0001568100-26-000031.md) | [20.0](/filings/0001568100-26-000045.md) |
| Gross profit | $m | [89.0](/filings/0001568100-24-000139.md) | [90.8 d](/filings/0001568100-26-000012.md) | [91.8](/filings/0001568100-25-000051.md) | [95.9](/filings/0001568100-25-000099.md) | [98.7](/filings/0001568100-25-000107.md) | [101 d](/filings/0001568100-26-000012.md) | [101](/filings/0001568100-26-000031.md) | [104](/filings/0001568100-26-000045.md) | [106](/filings/0001568100-25-000107.md) | [107 d](/filings/0001568100-26-000012.md) | [102](/filings/0001568100-26-000031.md) | [104](/filings/0001568100-26-000045.md) |
| Research and development | $m | [34.3](/filings/0001568100-24-000139.md) | [35.5 d](/filings/0001568100-26-000012.md) | [37.5](/filings/0001568100-25-000051.md) | [35.1](/filings/0001568100-25-000099.md) | [34.3](/filings/0001568100-25-000107.md) | [34.6 d](/filings/0001568100-26-000012.md) | [34.0](/filings/0001568100-26-000031.md) | [30.9](/filings/0001568100-26-000045.md) | [29.4](/filings/0001568100-25-000107.md) | [32.6 d](/filings/0001568100-26-000012.md) | [30.0](/filings/0001568100-26-000031.md) | [30.9](/filings/0001568100-26-000045.md) |
| Operating income | $m | [(20.8)](/filings/0001568100-24-000139.md) | [(33.4) d](/filings/0001568100-26-000012.md) | [(21.7)](/filings/0001568100-25-000051.md) | [(16.0)](/filings/0001568100-25-000099.md) | [(10.3)](/filings/0001568100-25-000107.md) | [(11.7) d](/filings/0001568100-26-000012.md) | [(10.3)](/filings/0001568100-26-000031.md) | [3.6](/filings/0001568100-26-000045.md) | [8.1](/filings/0001568100-25-000107.md) | [4.5 d](/filings/0001568100-26-000012.md) | [9.2](/filings/0001568100-26-000031.md) | [10.2](/filings/0001568100-26-000045.md) |
| Interest expense | $m | [1.5](/filings/0001628280-23-040445.md) | [2.3 d](/filings/0001568100-24-000021.md) | [2.1](/filings/0001568100-24-000058.md) | [2.4](/filings/0001568100-24-000109.md) | [2.4](/filings/0001568100-25-000107.md) | [2.4 d](/filings/0001568100-26-000012.md) | [2.4](/filings/0001568100-26-000031.md) | [2.3](/filings/0001568100-26-000045.md) | [2.1](/filings/0001568100-25-000107.md) | [2.1 d](/filings/0001568100-26-000012.md) | [2.1](/filings/0001568100-26-000031.md) | [2.1](/filings/0001568100-26-000045.md) |
| Income tax | $m | [(0.0)](/filings/0001568100-24-000139.md) | [0.2 d](/filings/0001568100-26-000012.md) | [0.2](/filings/0001568100-25-000051.md) | [0.4](/filings/0001568100-25-000099.md) | [0.7](/filings/0001568100-25-000107.md) | [0.4 d](/filings/0001568100-26-000012.md) | [0.8](/filings/0001568100-26-000031.md) | [(1.9)](/filings/0001568100-26-000045.md) | [(150)](/filings/0001568100-25-000107.md) | [(1.8) d](/filings/0001568100-26-000012.md) | [5.8](/filings/0001568100-26-000031.md) | [4.4](/filings/0001568100-26-000045.md) |
| Net income | $m | [(12.8)](/filings/0001568100-24-000139.md) | [(28.2) d](/filings/0001568100-26-000012.md) | [(17.1)](/filings/0001568100-25-000051.md) | [(10.9)](/filings/0001568100-25-000099.md) | [(5.9)](/filings/0001568100-25-000107.md) | [(8.8) d](/filings/0001568100-26-000012.md) | [(7.2)](/filings/0001568100-26-000031.md) | [9.6](/filings/0001568100-26-000045.md) | [162](/filings/0001568100-25-000107.md) | [9.4 d](/filings/0001568100-26-000012.md) | [5.3](/filings/0001568100-26-000031.md) | [7.8](/filings/0001568100-26-000045.md) |
| Diluted EPS | $ per share | [(0.16)](/filings/0001568100-24-000139.md) | not reported | [(0.26)](/filings/0001568100-25-000051.md) | [(0.14)](/filings/0001568100-25-000099.md) | [(0.07)](/filings/0001568100-25-000107.md) | not reported | [(0.07)](/filings/0001568100-26-000031.md) | [0.10](/filings/0001568100-26-000045.md) | [1.69](/filings/0001568100-25-000107.md) | not reported | [0.13](/filings/0001568100-26-000031.md) | [0.06](/filings/0001568100-26-000045.md) |
| Basic EPS | $ per share | [(0.16)](/filings/0001568100-24-000139.md) | not reported | [(0.26)](/filings/0001568100-25-000051.md) | [(0.14)](/filings/0001568100-25-000099.md) | [(0.07)](/filings/0001568100-25-000107.md) | not reported | [(0.07)](/filings/0001568100-26-000031.md) | [0.11](/filings/0001568100-26-000045.md) | [1.72](/filings/0001568100-25-000107.md) | not reported | [0.13](/filings/0001568100-26-000031.md) | [0.06](/filings/0001568100-26-000045.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2024 (2023-10-31) | FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [380](/filings/0001568100-24-000139.md) | [363](/filings/0001568100-26-000012.md) | [383](/filings/0001568100-25-000051.md) | [386](/filings/0001568100-25-000099.md) | [326](/filings/0001568100-25-000107.md) | [346](/filings/0001568100-26-000012.md) | [372](/filings/0001568100-26-000031.md) | [340](/filings/0001568100-26-000045.md) | [324](/filings/0001568100-25-000107.md) | [237](/filings/0001568100-26-000045.md) | [209](/filings/0001568100-26-000031.md) | [234](/filings/0001568100-26-000045.md) |
| Current assets | $m | [681](/filings/0001628280-23-040445.md) | [703](/filings/0001568100-25-000023.md) | [707](/filings/0001568100-24-000058.md) | [700](/filings/0001568100-24-000109.md) | [654](/filings/0001568100-24-000139.md) | [712](/filings/0001568100-26-000012.md) | [713](/filings/0001568100-25-000051.md) | [672](/filings/0001568100-25-000099.md) | [659](/filings/0001568100-25-000107.md) | [612](/filings/0001568100-26-000045.md) | [559](/filings/0001568100-26-000031.md) | [579](/filings/0001568100-26-000045.md) |
| Total assets | $m | [887](/filings/0001628280-23-040445.md) | [925](/filings/0001568100-25-000023.md) | [924](/filings/0001568100-24-000058.md) | [916](/filings/0001568100-24-000109.md) | [867](/filings/0001568100-24-000139.md) | [927](/filings/0001568100-26-000012.md) | [927](/filings/0001568100-25-000051.md) | [892](/filings/0001568100-25-000099.md) | [1,028](/filings/0001568100-25-000107.md) | [991](/filings/0001568100-26-000045.md) | [937](/filings/0001568100-26-000031.md) | [958](/filings/0001568100-26-000045.md) |
| Current liabilities | $m | [248](/filings/0001628280-23-040445.md) | [282](/filings/0001568100-25-000023.md) | [273](/filings/0001568100-24-000058.md) | [329](/filings/0001568100-24-000109.md) | [332](/filings/0001568100-24-000139.md) | [369](/filings/0001568100-26-000012.md) | [354](/filings/0001568100-25-000051.md) | [281](/filings/0001568100-25-000099.md) | [278](/filings/0001568100-25-000107.md) | [304](/filings/0001568100-26-000045.md) | [287](/filings/0001568100-26-000031.md) | [287](/filings/0001568100-26-000045.md) |
| Total liabilities | $m | [712](/filings/0001628280-23-040445.md) | [746](/filings/0001568100-25-000023.md) | [736](/filings/0001568100-24-000058.md) | [735](/filings/0001568100-24-000109.md) | [739](/filings/0001568100-24-000139.md) | [779](/filings/0001568100-26-000012.md) | [764](/filings/0001568100-25-000051.md) | [694](/filings/0001568100-25-000099.md) | [688](/filings/0001568100-25-000107.md) | [720](/filings/0001568100-26-000045.md) | [708](/filings/0001568100-26-000031.md) | [711](/filings/0001568100-26-000045.md) |
| Long-term debt | $m | not reported | [490](/filings/0001568100-24-000021.md) | not reported | not reported | not reported | [485](/filings/0001568100-25-000023.md) | not reported | not reported | not reported | [421](/filings/0001568100-26-000012.md) | not reported | not reported |
| Shareholders' equity | $m | [169](/filings/0001568100-24-000139.md) | [172](/filings/0001568100-26-000012.md) | [174](/filings/0001568100-25-000099.md) | [165](/filings/0001568100-25-000107.md) | [112](/filings/0001568100-25-000107.md) | [130](/filings/0001568100-26-000045.md) | [146](/filings/0001568100-26-000045.md) | [181](/filings/0001568100-26-000045.md) | [320](/filings/0001568100-25-000107.md) | [254](/filings/0001568100-26-000045.md) | [217](/filings/0001568100-26-000045.md) | [232](/filings/0001568100-26-000045.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2024 (2023-10-31) | Q4 FY2024 (2024-01-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q4 FY2025 (2025-01-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q4 FY2026 (2026-01-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [16.9 d](/filings/0001568100-24-000139.md) | [22.2 d](/filings/0001568100-26-000012.md) | [28.6](/filings/0001568100-25-000051.md) | [35.8 d](/filings/0001568100-25-000099.md) | [22.1 d](/filings/0001568100-25-000107.md) | [31.4 d](/filings/0001568100-26-000012.md) | [30.7](/filings/0001568100-26-000031.md) | [34.0 d](/filings/0001568100-26-000045.md) | [24.8 d](/filings/0001568100-25-000107.md) | [25.4 d](/filings/0001568100-26-000012.md) | [44.3](/filings/0001568100-26-000031.md) | [36.9 d](/filings/0001568100-26-000045.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001568100-24-000139.md) | [1.0 d](/filings/0001568100-26-000012.md) | [0.5](/filings/0001568100-25-000051.md) | [0.6 d](/filings/0001568100-25-000099.md) | [0.6 d](/filings/0001568100-25-000107.md) | [1.1 d](/filings/0001568100-26-000012.md) | [0.4](/filings/0001568100-26-000031.md) | [0.9 d](/filings/0001568100-26-000045.md) | [0.7 d](/filings/0001568100-25-000107.md) | [0.9 d](/filings/0001568100-26-000012.md) | [1.0](/filings/0001568100-26-000031.md) | [2.2 d](/filings/0001568100-26-000045.md) |
| Share repurchases | $m | [50.0 d](/filings/0001568100-24-000139.md) | [0.0 d](/filings/0001568100-26-000012.md) | not reported | not reported | [70.3 d](/filings/0001568100-25-000107.md) | [2.6 d](/filings/0001568100-26-000012.md) | [0.0](/filings/0001568100-26-000031.md) | [0.0 d](/filings/0001568100-26-000045.md) | [36.1 d](/filings/0001568100-25-000107.md) | [98.8 d](/filings/0001568100-26-000012.md) | [65.5](/filings/0001568100-26-000031.md) | [7.5 d](/filings/0001568100-26-000045.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2023 (2022-10-31) | Q1 FY2024 (2023-04-30) | Q2 FY2024 (2023-07-31) | Q3 FY2024 (2023-10-31) | Q1 FY2025 (2024-04-30) | Q2 FY2025 (2024-07-31) | Q3 FY2025 (2024-10-31) | Q1 FY2026 (2025-04-30) | Q2 FY2026 (2025-07-31) | Q3 FY2026 (2025-10-31) | Q1 FY2027 (2026-04-30) | Q2 FY2027 (2026-07-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [89.3](/filings/0001628280-23-040445.md) | [91.5](/filings/0001568100-24-000058.md) | [92.5](/filings/0001568100-24-000109.md) | [93.1](/filings/0001568100-24-000139.md) | [92.9](/filings/0001568100-25-000051.md) | [93.3](/filings/0001568100-25-000099.md) | [91.4](/filings/0001568100-25-000107.md) | [91.4](/filings/0001568100-26-000031.md) | [94.2](/filings/0001568100-26-000045.md) | [94.7](/filings/0001568100-25-000107.md) | [79.5](/filings/0001568100-26-000031.md) | [79.1](/filings/0001568100-26-000045.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 78,649,873 at 2026-08-25, from the cover of the [10-Q filed 2026-08-27](/filings/0001568100-26-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.